franklin.ai

Franklin.ai recommends… This month’s podcast recommendation is from Chris Warren, Head of Clinical Affairs at Franklin.ai: “Great insights from Dr Hugh Harvey, Managing Director of Hardian Health, on the roadmap to regulatory approval and commercialisation for AI systems in health. Dr Harvey highlights the importance of identifying intended use early to set up a successful regulatory and clinical strategy. He provides a great summary of the risk class levels and how this relates to intended use and economic viability of a product. This is brought together through an insightful discussion on AI tests and skin cancer diagnosis.”